The University of South Florida was awarded a $2,467,635 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "THE IM ABLE 2 STUDY: LONG TERM OUTCOMES TO ADVANCE CARE FOR WARRIORS AND VETERANS USING ADVANCED ANKLE FOOT ORTHOSES," will fund research to transform healthcare for military service members and veterans through innovative biomedical investigations. The 4-year award, beginning on June 15,...
This $953,125 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Florida to investigate MRI/MRS markers of skeletal muscle disease progression and vascular function in nonambulatory individuals with Duchenne muscular dystrophy. The research project will run from November 1, 2024 to October 31, 2027 and aims to advance understanding of neurodegenerative diseases...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $3,766,416.00 to The Regents of the University of California, San Francisco (UCSF) to conduct advanced biomedical research on expansile duraplasty for the treatment of acute traumatic spinal cord injury. The award has a performance period from July 1, 2025 to June 30, 2029. As a leading academic medical center and research institution, UCSF will leverage...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) in the amount of $1,765,321.00 was awarded to the University of Miami on September 30, 2023. The funding supports a four-year research project to develop functionalized peptide gels and utilize Schwann cells for repairing injured spinal cords. The University of Miami is the prime grantee and may collaborate with other research institutions as sub-grantees to execute...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $737,500.00 to Florida International University (FIU) to support a novel treatment for spinal cord injury-neuropathic pain by targeting fibroblast-derived PI16. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative medical solutions. FIU, a Hispanic-Serving Institution, will leverage its...
This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
This federal Project Grant award for $1,399,812.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant is awarded to the Regents of the University of Minnesota to conduct research on outcomes and late effects in pediatric and adolescent germ cell tumor survivors. This funding will enable...
The University of Florida was awarded a $152,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2025, supports advanced biomedical research aimed at "Targeting TIE2 as a Novel Strategy in VEGFR Inhibitor-Resistant Angiosarcoma" with a performance period ending on July 31, 2027. The Military Medical Research and Development program funds a diverse portfolio of scientific...